🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 17 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
08/02/2011 31,63 31,77 31,54 31,75 +0,82% 0,75% 12.437.874
07/02/2011 31,43 31,52 31,24 31,49 +0,33% 0,88% 15.175.354
04/02/2011 31,38 31,60 31,28 31,38 -0,03% 1,03% 26.485.894
03/02/2011 31,48 31,57 31,02 31,39 -2,72% 1,76% 42.170.367
02/02/2011 32,35 32,47 32,06 32,27 -0,53% 1,27% 14.453.492
01/02/2011 31,81 32,48 31,39 32,44 +2,50% 3,42% 22.434.012
31/01/2011 31,77 31,77 31,56 31,65 +0,30% 0,69% 14.836.431
28/01/2011 31,96 31,99 31,49 31,56 -0,54% 1,58% 16.927.191
27/01/2011 31,82 31,90 31,72 31,73 +0,15% 0,57% 16.217.695
26/01/2011 31,88 32,19 31,66 31,68 -0,48% 1,65% 27.418.195
25/01/2011 32,22 32,30 31,77 31,83 -1,30% 1,66% 34.185.760
24/01/2011 32,43 32,43 32,22 32,25 -0,29% 0,65% 20.575.908
21/01/2011 32,61 32,65 32,33 32,35 -0,44% 0,99% 21.779.850
20/01/2011 32,25 32,58 32,18 32,49 +0,41% 1,24% 22.645.184
19/01/2011 32,56 32,59 32,16 32,36 +0,12% 1,32% 31.174.437
18/01/2011 32,51 32,73 31,95 32,32 -1,05% 2,41% 61.805.800
14/01/2011 33,04 33,16 32,56 32,66 -1,33% 1,82% 43.755.467
13/01/2011 33,96 34,14 32,93 33,10 -6,62% 3,57% 77.860.531
12/01/2011 35,50 35,53 35,23 35,45 +0,54% 0,86% 13.507.567
11/01/2011 35,53 35,61 35,02 35,26 -0,67% 1,66% 10.725.861
10/01/2011 35,55 35,90 35,46 35,50 -0,40% 1,23% 11.238.438
07/01/2011 35,47 35,64 35,17 35,64 +0,78% 1,32% 13.365.668
06/01/2011 34,89 35,44 34,89 35,36 +1,37% 1,59% 12.565.834
05/01/2011 34,39 34,90 34,35 34,89 +0,58% 1,61% 15.217.274
04/01/2011 34,58 34,73 34,21 34,69 +0,86% 1,52% 14.594.553
03/01/2011 34,63 35,10 34,34 34,39 +0,00% 2,18% 20.498.356
31/12/2010 34,31 34,59 34,28 34,39 +0,08% 0,89% 5.755.406
30/12/2010 34,46 34,54 34,32 34,36 -0,55% 0,64% 5.359.158
29/12/2010 34,59 34,69 34,51 34,55 +0,03% 0,50% 5.243.144
28/12/2010 34,70 34,77 34,45 34,54 -0,08% 0,93% 5.679.846